Veracyte, Inc. VCYT

VCYT Company Overview

Veracyte, Inc. (VCYT) is a molecular diagnostics company operating in the precision medicine and clinical genomics industries. The company develops and commercializes genomic tests that help clinicians make more informed diagnostic and treatment decisions, particularly in oncology and pulmonary disease. Veracyte’s products are primarily used to improve diagnostic accuracy, reduce unnecessary invasive procedures, and guide personalized patient care.

The company’s core revenue is driven by its genomic diagnostic tests, most notably Afirma, Decipher, Percepta, and Envisia, which are ordered by physicians and reimbursed by commercial and government payers. Veracyte serves hospitals, academic medical centers, and community-based healthcare providers, with a strategic focus on high-impact diagnostic categories where traditional pathology has limitations. Founded in 2008, Veracyte evolved from a single-test diagnostics company into a multi-platform genomic diagnostics provider through internal development and acquisitions, expanding both its clinical focus and geographic reach.